Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive: Clinical Trials

1 trial for Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1
Phase 31Completed 1

Follow Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive: new trials by email Literature Review of Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive trials Research Report on Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Eltrombopag Olamine in Treating Thrombocytopenia in Patients With Chronic Myeloid Leukemia or Myelofibrosis Receiving Tyrosine Kinase Therapy
Eltrombopag Olamine - Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
Phase 2 / Phase 3CompletedM.D. Anderson Cancer Center212012-01-132023-09-26

Narrower conditions

Blast Crisis (1)  ·  Leukemia, Myeloid, Accelerated Phase (1)  ·  Leukemia, Myeloid, Chronic-Phase (1)  ·  Primary Myelofibrosis (1)  ·  Thrombocytopenia (1)

Broader conditions

Blood Platelet Disorders (1)  ·  Bone Marrow Diseases (1)  ·  Carcinogenesis (1)  ·  Cell Transformation, Neoplastic (1)  ·  Chronic Disease (1)  ·  Cytopenia (1)  ·  Disease Attributes (1)  ·  Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Leukemia (1)  ·  Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1)  ·  Leukemia, Myeloid (1)  ·  Myeloproliferative Disorders (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)

Interventions

eltrombopag (1)

Sponsors

M.D. Anderson Cancer Center (1)

Countries

United States (1)

Top investigators

Gautam Borthakur (1)